Thirty years of essential medicines in primary health care

Eastern Mediterranean Health Journal

Volumn 14, Issue SUPPL, 2009, Pages

  Mirza, Zafar ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84875182059     PISSN: 10203397     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. The selection of essential drugs: report of a WHO expert committee [meeting held in Geneva from 17 to 21 October 1977]. Geneva, World Health Organization, 1977 (WHO Technical Report Series, No. 615):20-30.
2. Declaration of Alma Ata (http://www.who.int/hpr/NPH/docs/declaration_almaata.pdf, accessed 3 July 2008).
3. Commission on Intellectual Property Rights, Innovation and Public Health. Public health, innovation and intellectual property rights: report of the Commission on Intellectual Property Rights, Innovation and Public Health. Geneva, World Health Organization, 2006.
4. Hardman JG, Limbird LE, eds. Goodman & Gilman's the pharmacological basis of therapeutics, 10th ed. New York, Mc-Graw-Hill, 2001.
5. WHO Official Records, No. 226, 1975, Annex 13, pp. 96-110.
6. World Health Assembly. Resolution WHA28.66. Geneva, World Health Organization, 1975.
7. Quick JD et al. Twenty-five years of essential medicines. Bulletin of the World Health Organization, 2002, 80(11):913-914.
8. Helling-Borda M. Memories of the First Expert Committee Meeting and celebrating 25 years later. Essential drugs monitor, 2003, 32:14-5.
9. World Health Assembly. Technical Cooperation. WHA resolution 30.43, 19 May 1977.
10. The use of essential drugs: second report of the WHO expert committee [meeting held in Geneva from 3 from 7 December 1984]. Geneva, World Health Organization, 1985 (WHO Technical Report Series, No. 722).
11. Mamdani M. Early initiatives in Essential Drugs Policy. In: Kanji N et al., eds. Drugs policy in developing countries. London, Zed Books, 1992:2.
12. Ferranti D. Paying for health services in developing countries: an overview. Washington DC, World Bank, 1985.
13. Guidelines for developing national drug policies. Geneva, World Health Organization, 1988.
14. The selection and use of essential medicines: report of the WHO Expert Committee, 2002 (including the 12th model list of essential medicines). Geneva, World Health Organization, 2003 (WHO Technical Report Series, No. 914).
15. The WHO Essential Medicines Library [website] (http://www.who.int/emlib/, accessed 3 July 2008).
16. The selection and use of essential medicines: report of the WHO Expert Committee, October 2007 (including the model list of essential medicines for children). Geneva, World Health Organization (in press).
17. Medicine prices: a new approach to measurement. Geneva, World Health Organization, 2003.